Novavax, Inc. (NVAX)
NASDAQ: NVAX · IEX Real-Time Price · USD
15.03
-0.22 (-1.44%)
At close: May 31, 2024, 4:00 PM
15.08
+0.05 (0.33%)
After-hours: May 31, 2024, 7:59 PM EDT
Novavax Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Novavax stock have an average target of 17.5, with a low estimate of 10 and a high estimate of 29. The average target predicts an increase of 16.43% from the current stock price of 15.03.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Novavax stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 2 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 2 | 2 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $11 → $29 | Strong Buy | Maintains | $11 → $29 | +92.95% | May 23, 2024 |
| TD Cowen | TD Cowen | Hold Maintains $5 → $10 | Hold | Maintains | $5 → $10 | -33.47% | May 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +26.41% | May 13, 2024 |
| B of A Securities | B of A Securities | Sell → Hold Upgrades $4 → $12 | Sell → Hold | Upgrades | $4 → $12 | -20.16% | May 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $35 → $19 | Strong Buy | Maintains | $35 → $19 | +26.41% | Mar 1, 2024 |
Financial Forecast
Revenue This Year
980.64M
from 983.71M
Decreased by -0.31%
Revenue Next Year
385.52M
from 980.64M
Decreased by -60.69%
EPS This Year
0.14
from -5.41
EPS Next Year
-1.01
from 0.14
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.1B | 561.3M | 604.4M | 1.2B | 1.2B |
| Avg | 980.6M | 385.5M | 319.3M | 1.1B | 1.1B |
| Low | 793.8M | 49.0M | 27.4M | 912.1M | 1.0B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.9% | -42.8% | 56.8% | 274.6% | 13.8% |
| Avg | -0.3% | -60.7% | -17.2% | 230.7% | 6.2% |
| Low | -19.3% | -95.0% | -92.9% | 185.7% | -2.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.27 | -0.12 | 2.16 | 0.39 | 0.23 |
| Avg | 0.14 | -1.01 | -0.22 | 0.09 | 0.21 |
| Low | -1.19 | -2.14 | -1.45 | -0.20 | 0.19 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 166.4% |
| Avg | - | - | - | - | 141.2% |
| Low | - | - | - | - | 114.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.